<?xml version="1.0" encoding="UTF-8"?>
<p>
 <bold>Definitions</bold>
 <list list-type="bullet">
  <list-item>
   <p>ADE: The process where cross-reactive IgG antibodies from a previous infection with poor neutralising capability bind the heterologous serotype and enhances its uptake via FcRs into host cells.</p>
  </list-item>
  <list-item>
   <p>ADE Antibody: Antibody that binds viral particles but does not prevent viral entry into host cells.</p>
  </list-item>
  <list-item>
   <p>Antigenic-Sin: The domination of cross-reactive memory CD8 T-cells from the original serotype during a heterotypic infection which have low avidity.</p>
  </list-item>
  <list-item>
   <p>Heterotypic: A different DENV serotype.</p>
  </list-item>
  <list-item>
   <p>Homotypic: The same DENV serotype.</p>
  </list-item>
  <list-item>
   <p>Cross-reactive: Immune cells which react to multiple serotypes.</p>
  </list-item>
  <list-item>
   <p>Epitope Variants: Epitopes across serotypes with sequence differences between serotypes.</p>
  </list-item>
  <list-item>
   <p>Purifying Selection: Amino acid changes fixed by fitness advantage.</p>
  </list-item>
  <list-item>
   <p>Positive Selection: Amino acid changes fixed by chance.</p>
  </list-item>
 </list>
</p>
